Prescription sales up 5.1%, IMS reports

Share this content:
U.S. sales of ethical pharmaceuticals and insulins grew by 5.1% last year to $300 billion,  according to a report from IMS Health. “In 2009, demand for pharmaceuticals proved stronger than in the prior two years, yet remained at historically low levels,” said IMS's Murray Aitken.

Next Article in Products